Private Placement

In under three years, Tema ETFs has attracted billions, largely from institutions, by combining top-performing active funds with unique access to SpaceX.

San Diego's Blacksmith Medicines will present promising data on its FEN1 inhibitor, a new drug targeting a notoriously difficult class of enzymes.

A four-legged robot powered by physical AI is set to revolutionize heavy industry by tackling the welder shortage and bringing automation to the field.

A new integration between Supio and Thomson Reuters Westlaw Advantage promises to eliminate research silos, merging AI case intelligence with legal research.

A new fund is funneling investment into rare earth projects outside China, and a Canadian company's inclusion could be a game-changer for the West.

A new $15M contract funds PlanetiQ's advanced satellites, giving the U.S. Air Force an unprecedented strategic edge with next-generation weather data.

A new partnership combines AI-driven robotics and atomic-scale manufacturing to accelerate the discovery of next-gen materials for a high-tech future.

A new AI tool won a top prize by giving injured claimants a real-time digital ally during confusing calls with insurance adjusters. Is this the future?

A new platform aims to unify global capital with 24/7 access to tokenized US and Hong Kong equities, challenging the current state of real-world assets.

A company named for mining is betting big on Bali's luxury villa market. But with a tiny market cap and an unknown builder, is it a brilliant pivot or a risky gamble?

The struggling footwear brand is selling its assets to become NewBird AI, a GPU provider. Is it a visionary gamble or a desperate move in the AI gold rush?

With a new billion-dollar brand builder as CFO and $1.5B in backing, Montera is poised to challenge leaders in the booming AI infrastructure market.

Bengaluru-based SeedlingLabs unveils Orchard and Sprout, autonomous AI systems designed to overhaul software testing and educational workflows.

Houston PE firm EIV Capital adds 30-year veteran Mo Bawa as Partner, a strategic move to bolster its leadership in a competitive energy investment landscape.

With $108M in new funding, Terremoto Biosciences advances a novel class of drugs designed to overcome the toxicities of past cancer treatments.

Automotive veteran Christian Mohrdieck is now CEO of Pajarito Powder, aiming to scale the foundational catalyst tech needed for a global hydrogen economy.

With new top-tier executives, Danish biotech MinervaX is accelerating its quest to deliver the world's first vaccine against a leading cause of infant death.

With a fresh $28M investment, Verismo Therapeutics is set to unveil groundbreaking KIR-CAR data, aiming to revolutionize CAR T therapy for solid tumors.

The lithium developer reports lower losses and a surprising new strategy: drilling for oil to fund its major green energy project in Saskatchewan.

A new survey finds most employees would rather do their taxes than work in a bad office, revealing a costly crisis in workspace design and morale.